RMC No. 34-2024: FDA Updates to VAT-Exempt Medicines for Cancer, Hypertension, and Mental Illness Under TRAIN and CREATE

RMC No. 34-2024 confirms FDA updates to VAT-exempt medicines for cancer, hypertension, and mental illness, with effect from FDA publication. Businesses selling medicines for cancer, hypertension, and mental illness must immediately check the latest Food and Drug Administration updates to the VAT-exempt product list because VAT exemption takes effect on the date the FDA publishes […]

RMC No. 30-2022: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, High Cholesterol, Mental Illness, and COVID-19

RMC No. 30-2022 updates the VAT-exempt medicines list under CREATE, covering specified medicines and requiring sellers to review VAT treatment. Pharmacies, hospitals, clinics, drug distributors, importers, and VAT-registered sellers of medicines must immediately verify whether the medicines they sell, dispense, import, or purchase are included in the updated VAT-exempt medicines list endorsed by the Food […]

RMO No. 25-2020: RDO at the Port of Entry Must Process ATRIG Applications for VAT-Exempt Imported Prescription Drugs and Medicines

RMO No. 25-2020 requires ATRIG applications for VAT-exempt imported prescription drugs and medicines to be processed by the port-of-entry RDO. Importers of VAT-exempt prescription drugs and medicines must file their Authority to Release Imported Goods applications with the Revenue District Office having jurisdiction over the port of entry, because RMO No. 25-2020 immediately amended the […]

RR No. 25-2018: VAT Exemption on Diabetes, High Cholesterol, and Hypertension Medicines Starting January 1, 2019

RR No. 25-2018 exempts FDA-listed diabetes, cholesterol, and hypertension medicines from VAT on local sale starting January 1, 2019. Starting January 1, 2019, businesses selling covered medicines for diabetes, high cholesterol, and hypertension must treat qualified sales as VAT-exempt, but only if the drug or medicine is included in the official VAT-exempt list identified and […]